In particular, the authors showed that SNX-2112 downregulated IKKα, IKKβ and Akt expression in AML cells leading to IκB upregulation, NF-κB/p65 inhibition and modulation of PU.1 and C/EBPα expression [151]. Here, CEBPA is linked to acute myeloid leukemia.